ALX Oncology Company
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Industry:
Biopharma, Biotechnology, Health Care, Life Science, Therapeutics
Last Funding Date:
2020
Investors Number:
10
Technology:
Cancer
Last Funding Type:
Initial Coin Offering
Headquarters:
San Francisco, California, United States
Founded Date:
2015
Investor Type:
IPO
Funding Status:
IPO
Total Funding:
166000000
Estimated Revenue:
Less than $1M
Employee Number:
11-50